Inhibition of hepatic tumor cell proliferation in vitro and tumor growth in vivo by taltobulin, a synthetic analogue of the tripeptide hemiasterlin

Figure 5 In vivo inhibition of tumor growth under HTI-286 treatment. HTI-286 was injected on d 1, 5, 9 and 15. By d 7, tumor growth significantly differed between the control and HTI-286 group (^aP = 0.042; ^bP = 0.0001). Two weeks after the last HTI-286 injection, the inhibitory effect was diminished between both groups (P = 0.056).